All Immunology articles – Page 5
-
NewsImmunity against common virus leveraged against pancreatic cancer
Researchers have discovered a promising new treatment approach for pancreatic cancer. The approach leverages the body’s natural immune response to cytomegalovirus (CMV), a common but typically harmless virus that most people are infected with at some point in their lives.
-
NewsOne strategy to block both drug-resistant bacteria and influenza: new broad-spectrum infection prevention approach validated
A new paper moves beyond traditional infection control strategies reliant on antibiotics and vaccines by introducing a new approach that primes the immune system before infection occurs.
-
NewsHIV antibody opens up new approaches for vaccine development and combination therapies
An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site and overcomes previous limitations of known antibodies. The study opens up new perspectives for the development of vaccines and therapeutics against HIV-1.
-
NewsEleven genetic variants affect the gut microbiome
In two new studies on 28,000 individuals, researchers are able to show that genetic variants in 11 regions of the human genome have a clear influence on which bacteria are in the gut and what they do there. Only two genetic regions were previously known.
-
NewsBasic research on Listeria bacteria leads to unique cancer therapy
After nearly 40 years of research on how Listeria bacteria manipulate our cells and battle our immune system to cause listeriosis, researchers have discovered a way to turn the bacteria into a potent booster of the immune system — and a potential weapon against cancer.
-
NewsHPV cancer vaccine slows tumor growth, extends survival in preclinical model
Scientists discovered that systematically changing the orientation and placement of a single cancer-targeting peptide can lead to formulations that supercharge the immune system’s ability to attack HPV-driven tumors.
-
NewsResearchers solve mystery behind rare clotting after adenoviral vaccines or natural adenovirus infection
Scientists have uncovered why a small number of people developed dangerous blood clots after either receiving certain COVID‑19 vaccines or experiencing a natural adenovirus infection - the answer lies in an unexpected case of misdirected targeting by the immune system.
-
NewsVirus-based therapy boosts anti-cancer immune responses to brain cancer
A study has shown that a single injection of an oncolytic virus—a genetically modified virus that selectively infects and destroys cancer cells—can recruit immune cells to penetrate and persist deep within brain tumors.
-
NewsHow food shortages reprogram the immune system’s response to infection
When food is scarce, stress hormones direct the immune system to operate in “low power” mode to preserve immune function while conserving energy. This reconfiguration is crucial to combating infections amid food insecurity.
-
NewsUS study finds declining perception of safety of COVID-19, flu, and MMR vaccines
A sizable majority of Americans think the three vaccines that combat potentially deadly illnesses flu, Covid-19 and measles are safe to take, although perceptions of the safety of all three vaccines showed a statistically significant drop over the past three years.
-
NewsStudy reveals how chills develop and support the body’s defense against infection
Researchers in Japan have identified the neural mechanism behind chills and the instinct to increase body temperature during infection.
-
NewsLong COVID linked to Alzheimer’s disease mechanisms
The increased size of, and lesser blood supply to, a key brain structure in patients with Long COVID tracks with known blood markers of Alzheimer’s disease and greater levels of dementia, a new study finds.
-
NewsNew gut-brain discovery offers hope for treating ALS and dementia
Scientists have identified a link between gut bacteria and the deterioration of the brain in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). The researchers discovered that certain bacterial sugars cause immune responses that kill cells—and how to prevent it.
-
News Engineered moths could replace mice in research into “one of the biggest threats to human health”
Scientists have created the world’s first genetically engineered wax moths – a development which could both accelerate the fight against antimicrobial resistance (AMR) and significantly reduce the need for mice and rats in infection research.
-
NewsWhat drives food allergies? New study pinpoints early-life factors that raise risk - including microbiome
A new study involving 2.8 million children around the world has revealed the most important early-life factors that influence whether a child becomes allergic to food. Genetics alone cannot fully explain food allergy trends, pointing to interactions between genes, skin health, the microbiome, and environmental exposures.
-
NewsEthris and German Center for Infection Research (DZIF) announce strategic collaboration to develop mRNA-based vaccines
Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center for Infection Research (DZIF), have announced a strategic research collaboration to develop mRNA-based vaccines for the prevention and treatment of infectious diseases.
-
NewsResearchers on the cusp of a vaccine for a global health threat
Researchers are on the cusp of a new vaccine to prevent chikungunya, a global health threat which attacks human joint tissue. The team tested whether they could engineer E. coli to assemble biopolymer particles which displayed chikungunya antigens and performed as a vaccine.
-
NewsConstruction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases
A new article discusses the construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases.
-
NewsDiscovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model
A new article publication discusses the discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model.
-
NewsNew study: Immune cells linked to Epstein-Barr virus may play a role in MS
Researchers have found that certain types of CD8+ “killer” T cells — immune cells that destroy damaged or infected cells — are more abundant in people with MS. Some of these killer T cells target EBV, which suggests that the virus may trigger the damaging immune response seen in MS.